ArticleACS nanoscience Au2024
Molecular Additives as Competitive Binding Agents to Control Supramolecular-Driven Nanoparticle Assembly.
Article in ACS nanoscience Au, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colloidal nanoparticle assembly methods can produce intricate superlattice structures and often use knowledge of atomic crystallization behaviors to guide their design. While this analogy has enabled multiple routes to programming colloidal crystallization thermodynamics, fewer tools or strategies exist to manipulate nanoparticle superlattice growth kinetics in a controlled manner. Here we investigate how small-molecule additives can be used to modulate the thermodynamics and kinetics of supramolecular-chemistry-driven nanoparticle assembly. Specifically, we introduce monovalent binding agents into the superlattice growth solution that compete with the multivalent interparticle bonding interactions driving particle assembly, thereby altering interparticle bond strength by reducing the number of bridging complexes formed between particles. In this manner, the assemblies can be steered to avoid kinetic traps and crystallize into faceted single crystals under isothermal conditions, alleviating the need for precise thermal control that has conventionally been required to produce large, faceted crystals in prior assembly methods.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.